Review of topiramate for the treatment of epilepsy in elderly patients.
Individuals over 65 years of age experience the new onset of seizures at a prevalence rate of roughly twice that of younger adults. Differences in physiology, need of concomitant medications, and liability for cognitive deficits in this population, make the choice of anticonvulsant drugs especially important. This paper reviews topiramate (TPM), a treatment for many types of seizures, with the above risks in mind. In particular, we discuss efficacy and pharmacokinetics with emphasis on the older patient, and adverse events in both the younger and older adult. With most studies of TPM-induced cognitive deficits having been performed in younger adults and volunteers, we discuss the implications for the older adult. Even in studies of younger individuals, up to 50% discontinue TPM because of intolerable cognitive deficits. Most studies find specific declines in working memory and verbal fluency. In conclusion, we give recommendations for use of this antiepileptic drug in this population.
Sommer
B R
BR
Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305-5723, USA. brsommer@stanford.edu
Fenn
H H
HH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D005632:Fructose / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008875:Middle Aged; D000077236:Topiramate; D055815:Young Adult
D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose
Seizure. 2005 Sep;14(6):371-80
15961326
CNS Neurosci Ther. 2008 Summer;14(2):120-42
18482025
Epilepsia. 1993 May-Jun;34(3):453-68
8504780
Ann Clin Psychiatry. 2001 Dec;13(4):185-9
11958360
Neurology. 2003 May 13;60(9):1483-8
12743236
Clin Neuropharmacol. 2001 Sep-Oct;24(5):284-9
11586113
Neurology. 1996 Jun;46(6):1678-83
8649569
Drugs. 1997 Nov;54(5):752-73
9360061
Epilepsia. 2000;41(S1):77-81
10768306
Epilepsia. 2000;41(S1):3-9
10768292
Epilepsia. 1999 Dec;40(12):1767-74
10612342
Neurology. 1996 Jun;46(6):1684-90
8649570
Epilepsy Behav. 2006 Jun;8(4):736-41
16647301
Epilepsia. 1996 Oct;37(10):951-5
8822693
Acta Neurol Scand. 2003 Mar;107(3):165-75
12614309
Drug Saf. 2007;30(7):555-67
17604407
Epilepsia. 2003 May;44(5):659-63
12752464
Arch Neurol. 2008 Nov;65(11):1467-71
19001165
Exp Gerontol. 2003 Aug;38(8):843-53
12915206
Clin Geriatr Med. 1988 Feb;4(1):127-49
3278786
Neurology. 2004 Mar 9;62(5 Suppl 2):S24-9
15007161
Ann Clin Biochem. 2004 Mar;41(Pt 2):166-9
15025812
J Affect Disord. 2005 Aug;87(2-3):243-52
15985295
J Anal Toxicol. 2006 Oct;30(8):599-602
17132258
Expert Opin Drug Saf. 2007 Sep;6(5):547-57
17877442
J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):44-50
10369821
Clin Pharmacokinet. 2004;43(12):763-80
15355124
Acad Emerg Med. 2009 Mar;16(3):193-200
19154565
Drug Saf. 2001;24(13):991-1015
11735655
Neurology. 2004 Aug 24;63(4):762; author reply 762
15326274
Seizure. 2002 Jun;11(4):255-60
12027573
Neurology. 2003 Jan 28;60(2):196-202
12552030
Lancet. 2000 Apr 22;355(9213):1441-6
10791538
Clin Ther. 1997 Nov-Dec;19(6):1294-308
9444441
J Clin Neurol. 2006 Jun;2(2):126-33
20396496
Epilepsia. 1996;37 Suppl 2:S18-S22
8641242
Neurology. 2005 Jun 28;64(12):2108-14
15985582
Acta Neurol Scand. 2008 Sep;118(3):164-74
18384458
Clin Pharmacokinet. 2006;45(11):1061-75
17048972
Am J Kidney Dis. 2006 Oct;48(4):555-63
16997051
Arch Neurol. 2000 Dec;57(12):1727-31
11115238
J Psychosom Res. 2008 Sep;65(3):249-54
18707947
Epilepsy Behav. 2006 Feb;8(1):161-8
16266829
Epilepsia. 2008 Jul;49(7):1180-5
18494791
Epilepsia. 2000;41(S1):66-71
10768304
Epilepsia. 2000;41(S1):35-9
10768298
Epilepsia. 1996 Aug;37(8):763-8
8764816
Neurology. 2006 Aug 8;67(3):400-6
16894098
Epilepsia. 1996 Mar;37(3):224-9
8598179
Psychosomatics. 2005 Jul-Aug;46(4):302-16
16000673
Epilepsia. 2005 Feb;46(2):298-303
15679511
Pain Med. 2008 Mar;9(2):175-85
18298700
Epilepsy Behav. 2005 May;6(3):373-81
15820346
Epilepsia. 2008 Jul;49(7):1239-76
18397299
Epilepsia. 2001 Sep;42(9):1134-40
11580760
Acta Neurol Scand Suppl. 2005;181:40-6
16238708
Epilepsy Behav. 2006 Feb;8(1):181-91
16377253
Epilepsy Behav. 2009 Mar;14(3):556-9
19150415
Epilepsy Res. 2006 Jan;68 Suppl 1:S49-63
16207524
Epilepsia. 1997 Mar;38(3):294-300
9070591
Drug Saf. 2007;30(2):123-42
17253878
Epilepsia. 2000 Sep;41(9):1167-78
10999556
Epilepsy Behav. 2004 Oct;5(5):716-21
15380124
J Clin Pharmacol. 1996 Oct;36(10):884-91
8930774
Epilepsia. 2002 Apr;43(4):365-85
11952767
Epilepsia. 2005 Mar;46(3):378-84
15730535
Lancet. 2000 Apr 15;355(9212):1315-9
10776744
Arch Ophthalmol. 2002 Aug;120(8):1108
12149075
Neurology. 2005 Mar 8;64(5):792-8
15753411
Acta Neurol Scand. 2005 Sep;112(3):144-50
16097955
Lancet. 2007 Mar 24;369(9566):1016-26
17382828
Neurologist. 2003 Sep;9(5):241-9
12971835
Epilepsy Behav. 2003 Oct;4 Suppl 2:S25-38
14527481
Acta Neurol Scand. 2005 Oct;112(4):214-22
16146489
Ann Pharmacother. 2005 Nov;39(11):1852-60
16189285
Neurology. 2007 Oct 23;69(17):1657-64
17954781
Lancet. 2000 Oct 7;356(9237):1255-9
11072960
Epilepsia. 1996 Jun;37(6):539-43
8641230
Epilepsy Res. 2003 May;54(2-3):171-8
12837568
Epilepsy Res. 1996 Nov;25(3):217-24
8956919
Neurology. 2003 Nov 11;61(9):1306
14610152
Epilepsy Res. 2008 Feb;78(2-3):140-6
18155445
Seizure. 2008 Jan;17(1):19-26
17618131
Epilepsia. 2002 Jul;43(7):691-6
12102670
Drug Saf. 2001;24(7):513-36
11444724
Drugs Aging. 1999 Oct;15(4):255-69
10582773